{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:42:19Z","timestamp":1791250939605,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["NS 067283"],"award-info":[{"award-number":["NS 067283"]}]},{"name":"Brain Science Flagship","award":["2E24380"],"award-info":[{"award-number":["2E24380"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.bbadis.2013.09.017","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T18:39:58Z","timestamp":1383244798000},"page":"785-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Nucleolar dysfunction in Huntington's disease"],"prefix":"10.1016","volume":"1842","author":[{"given":"Junghee","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil W.","family":"Kowall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2013.09.017_bb0310","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1093-168","article-title":"De novo expansion of a (CAG)n repeat in sporadic Huntington\u2019s disease","volume":"5","author":"Myers","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0315","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","article-title":"A worldwide study of the Huntington\u2019s disease mutation the sensitivity and specificity of measuring CAG repeats","volume":"330","author":"Kremer","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0320","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0325","first-page":"317","article-title":"On chorea","volume":"26","author":"Huntington","year":"1872","journal-title":"Med. Surg. Rep."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0330","first-page":"995","article-title":"Nue anatomische befunde bei paralysis agitans und bei chronischer progressive chorea","volume":"27","author":"Jergelsma","year":"1908","journal-title":"Neurol. Centralbl."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0335","first-page":"83","article-title":"Huntinton\u2019s chorea: current neuropathological status","volume":"23","author":"Bruyn","year":"1979"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0340","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0345","series-title":"Neuropathology of Dementing Disorders","first-page":"219","article-title":"Huntington\u2019s disease","author":"Kowall","year":"1998"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0010","series-title":"Movement Disorders: Neurologic Principles and Practice","first-page":"503","article-title":"Neuropathology and pathophysiology of Huntington\u2019s disease","author":"Hersch","year":"2004"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington\u2019s disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0304-3940(86)90634-8","article-title":"Topography of encephalin, substance P and acetylcholinesterase staining in Huntington\u2019s disease striatum","volume":"71","author":"Ferrante","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005072-198701000-00002","article-title":"Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington\u2019s disease","volume":"1","author":"Ferrante","year":"1987","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0030","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1523\/JNEUROSCI.11-12-03877.1991","article-title":"Proliferative and degenerative changes in striatal spiny neurons in Huntington\u2019s disease: a combined study using the section-Golgi method and calbindin D28K immunocytochemistry","volume":"11","author":"Ferrante","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0035","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0040","first-page":"24","article-title":"Patterns of cell loss in Huntington\u2019s disease","volume":"10","author":"Kowall","year":"1987","journal-title":"TINS"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0045","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"Huntington\u2019s disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"Spada","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng0793-221","article-title":"Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1","volume":"4","author":"Orr","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(03)00569-5","article-title":"Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport","volume":"40","author":"Szebenyi","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0065","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0070","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0896-6273(00)80405-5","article-title":"Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?","volume":"19","author":"Ross","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0075","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0080","first-page":"34","article-title":"Dysfunction of wild-type huntingtin in Huntington disease","volume":"18","author":"Cattaneo","year":"2003","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1471-4159.2003.01980.x","article-title":"Depletion of wild-type huntingtin in mouse models of neurologic diseases","volume":"87","author":"Zhang","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0090","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med. Suppl."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0095","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0105","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0092-8674(00)80464-X","article-title":"Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse","volume":"91","author":"Ordway","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrn1386","article-title":"Experimental therapeutics in transgenic mouse models of Huntington\u2019s disease","volume":"5","author":"Beal","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pharmthera.2005.04.008","article-title":"The therapeutic role of creatine in Huntington\u2019s disease","volume":"108","author":"Ryu","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0120","first-page":"18","article-title":"The epigenotype","volume":"1","author":"Waddington","year":"1942","journal-title":"Endeavour"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2007.02.006","article-title":"Epigenetics: a landscape takes shape","volume":"128","author":"Goldberg","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ncpneuro0199","article-title":"Mechanisms of disease: histone modifications in Huntington\u2019s disease","volume":"2","author":"Sadri-Vakili","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/321209a0","article-title":"CpG-rich islands and the function of DNA methylation","volume":"321","author":"Bird","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14728214.10.2.345","article-title":"Emerging chemotherapeutic strategies for Huntington\u2019s disease","volume":"10","author":"Ryu","year":"2005","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jsb.2007.05.004","article-title":"The giant fibrillar center: a nucleolar structure enriched in upstream binding factor (UBF) that appears in transcriptionally more active sensory ganglia neurons","volume":"159","author":"Casafont","year":"2007","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0150","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/35080045","article-title":"The function and synthesis of ribosomes","volume":"2","author":"Lafontaine","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0155","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1242\/jcs.113.24.4463","article-title":"Characterisation of transcriptionally active and inactive chromatin domains in neurons","volume":"113","author":"Akhmanova","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.cellbio.24.110707.175259","article-title":"The epigenerics of rRNA genes: from molecular to chromosome biology","volume":"24","author":"McStay","year":"2008","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0165","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/cdd.2011.38","article-title":"Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington\u2019s disease","volume":"18","author":"Lee","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/cdd.2013.66","article-title":"A neuroprotective phase precedes striatal degeneration upon nucleolar stress","author":"Kreiner","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0175","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1093\/nar\/gkn484","article-title":"The splice variants of UBF differentially regulate RNA polymerase I transcription elongation in response to ERK phosphorylation","volume":"36","author":"Stefanovsky","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0180","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1073\/pnas.88.8.3180","article-title":"Identification of two forms of the RNA polymerase I transcription factor UBF","volume":"88","author":"O\u2019Mahony","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0185","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1073\/pnas.93.16.8750","article-title":"Overexpression of the transcription factor UBF1 is sufficient to increase ribosomal DNA transcription in neonatal cardiomyocyte: implications for cardiac hypertrophy","volume":"93","author":"Hannan","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0190","doi-asserted-by":"crossref","first-page":"15106","DOI":"10.1073\/pnas.0404767101","article-title":"Upstream binding factor association induces large-scale chromatin decondensation","volume":"101","author":"Chen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0195","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1083\/jcb.200805146","article-title":"UBF levels determine the number of active ribosomal RNA genes in mammals","volume":"183","author":"Sanij","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0200","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/nar\/gkl101","article-title":"Acetylation of UBF changes during the cell cycle and regulates the interaction of UBF with RNA polymerase I","volume":"34","author":"Meraner","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/384641a0","article-title":"The CBP co-activator is a histone acetyltransferase","volume":"384","author":"Bannister","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0210","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuron.2004.05.021","article-title":"Chromatin acetylation, memory, and LTP are impaired in CBP+\/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration","volume":"42","author":"Alarc\u00f3n","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0215","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuron.2004.06.002","article-title":"CBP histone acetyltransferase activity is a critical component of memory consolidation","volume":"42","author":"Korzus","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0220","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0225","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pneurobio.2010.01.002","article-title":"Epigenetic regulation in the pathophysiology of Alzheimer's disease","volume":"90","author":"Chouliaras","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0230","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02736773","article-title":"Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer\u2019s disease patient","volume":"6","author":"West","year":"1995","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0235","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","article-title":"Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease","volume":"24","author":"Ferrante","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0240","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington\u2019s disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0245","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","article-title":"ESET\/SETDB1 gene expression and histone H3(K9) trimethylation in Huntington\u2019s disease","volume":"103","author":"Ryu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0250","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models","volume":"16","author":"Sadri-Vakili","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0255","doi-asserted-by":"crossref","first-page":"e41423","DOI":"10.1371\/journal.pone.0041423","article-title":"Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease","volume":"7","author":"McFarland","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0260","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0092-8674(02)00798-5","article-title":"Histone methylation: dynamic or static?","volume":"109","author":"Bannister","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0265","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1128\/MCB.19.8.5504","article-title":"Histone deacetylase 1 can repress transcription by binding to SP1","volume":"19","author":"Doetzlhofer","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0270","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/cdd.2011.196","article-title":"ATRX induction by mutant huntingtin via Cdx2 modulates heterochromatin condensation and pathology in Huntington\u2019s disease","volume":"19","author":"Lee","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0275","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.onc.1204998","article-title":"Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor","volume":"21","author":"Yang","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0280","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nsmb.1778","article-title":"PHF8 activates transcription of rRNA genes through H3K4me3 binding and H3K9me1\/2 demethylation","volume":"17","author":"Feng","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0285","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00401-013-1103-z","article-title":"Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington's disease","volume":"125","author":"Lee","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0290","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01080","article-title":"Active genes are tri-methylated at K4 of histone H3","volume":"419","author":"Santos-Rosa","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0295","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4161\/cc.5.7.2633","article-title":"Regulation of rRNA synthesis in human and mouse cells is not determined by changes in active gene count","volume":"5","author":"Stefanovsky","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbadis.2013.09.017_bb0300","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1111\/j.1460-9568.2004.03765.x","article-title":"Benefit of valproic acid in suppressing disease progression of ALS model mice","volume":"20","author":"Sugai","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.017_bb0305","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2005.02.022","article-title":"Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis","volume":"164","author":"Camelo","year":"2005","journal-title":"J. Neuroimmunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913003050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913003050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T04:52:21Z","timestamp":1646974341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443913003050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0925443913003050"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.09.017","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nucleolar dysfunction in Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}